Searched for
HOSPITAL PRICING
Stop the price scam in our hospitalsA recent investigation in Maharashtra has shed light on concerning price hikes for medical supplies charged to patients. Items such as IV i...- For investors with a 3- to 5-year horizon: 5 mid-cap stocks from different sectors with upside potential of more than 19%A development worth noting is that there was net FII buying in five of the last six trading sessions. But it is still tentative, and cannot...
- The business of running a hospital: Balancing profitability, patient trust and scaleA hospital’s financial health depends on more than occupancy and revenue, requiring a careful balance of cost control, cash flow and patien...
- Hunting for Diwali winners? 8 brokerages name 58 stocks with big upside potential; Eternal, L&T among top picksEight brokerages have shortlisted 58 stocks for their Diwali 2026 portfolios across sectors such as banking, IT, defence, automobiles and h...
- Oyo parent PRISM clocks PAT of Rs 353 crore in Q1, up 17% YoY, revenue jumps 35%Oyo parent PRISM reported a 35% YoY rise in Q1FY27 revenue to Rs 2,814 crore, while net profit grew 17% to Rs 353 crore. Gross Booking Valu...
- 4 stocks with consistent score improvement and upside potential of up to 31% in 1 year, according to analystsAlthough the indices are in the green on Monday, the market is extremely volatile. The upmove is being attributed to some recovery in oil p...
- Commercial LPG price hiked by Rs 10; ATF rates up Rs 1.37 per litre from November 1From November 1, the price of a 19-kg commercial LPG cylinder increased by Rs 10 to Rs 2,820. Aviation turbine fuel prices have also risen ...
- Dubai in Transit: The megalopolis is trying to shake off nightmarish war months, but caution remains in the airDubai is struggling to regain business momentum eight months after Iranian missile strikes disrupted tourism, real estate and other sectors...
- Short-term headwinds, yes; owning the ecosystem is better: 20 healthcare stocks with downside risk of 23% to upside potential of 41%The healthcare sector is under scrutiny. The issue is pricing: What medicines cost and on what hospitals and the rest of the health ecosyst...
- Karnataka govt pauses circular on medicine price disclosure by hospitalsIn a significant move, the Karnataka government declared it would not proceed with a disputed circular aimed at mandating hospitals to disc...
- India’s drug pricing policy must balance affordability, medicine availability and pharma industry growthThe Government of India has recently capped trade margins on anti-cancer medicines at 30%. This decision has reignited the ongoing discussi...
- Anti-cancer medicines: How to protect the patient today without weakening India's healthcare capacity for tomorrowIndia should examine trade margins across medicines, medical devices and consumables using a common, scientifically credible method - not a...
- Beyond Hotels: Salil Panigrahi on Building the Indian Ocean’s Next Lifestyle Ecosystem
- Cancer drug price cuts leave costly brands untouchedPrices of several anti-cancer drugs are set to fall significantly starting November 9, offering some financial relief. However, the prices ...
- Global Market: Malaysia's Asia OneHealthcare files draft prospectus for IPO of up to 4.38 billion sharesMalaysian hospital operator Asia OneHealthcare has filed for an IPO of up to 4.38 billion shares on Bursa Malaysia. The TPG-backed company ...
- Superstar Mamootty, worth Rs 340 crore, barely invested in startups, but one he had shares in earned over Rs 800 crore in 2025. CA says, 'He has a good…’The Bramayugam actor was previously a stakeholder in Motherhood, a maternal health venture run by his daughter, Surumy, and her spouse, Dr ...
- Cancer care can be cheaper: 6 steps to cut drug costsIndia has capped trade margins at 30% on 137 non-scheduled anti-cancer drugs to reduce treatment costs. Experts call for standardised care,...
- Paras Healthcare shares to list today: Check GMP ahead of debutThe Rs 1,450-crore IPO comprised a fresh issue of 72.15 lakh shares worth Rs 500 crore and an offer for sale (OFS) of 1.37 crore shares agg...
- Rs 1 lakh to Rs 30,000: Cancer immunotherapy gets cheaper, but will patients get the price benefit?Cheaper nivolumab biosimilars are expanding access to cancer immunotherapy in India, with one Mumbai oncologist reporting a more than 50% r...
- Hospitals overcharge patients upto 700% on medicines while India makes some of the world’s lowest priced drugs: Centre admits to SCGovt has told Supreme Court that hospitals overcharging patients for medicines and medical consumables is a malpractice. Its affidavit cite...
Load More
